Literature DB >> 29123282

Diagnosis and management of oral candidosis.

M A O Lewis1, D W Williams1.   

Abstract

Candida is a fungus (yeast) that is generally regarded as a normal and harmless member of the oral microbiome in humans. Should host defences against these commensals be compromised in any way then Candida can cause clinical signs and symptoms, which manifest as distinct forms of oral candidosis (candidiasis). Candida albicans is the most frequently isolated candidal species from the oral cavity, although a range of non-C. albicans Candida species are being increasingly encountered. The basic principle of the management of candidosis is to identify and eliminate any underlying host predisposing factor. However, in many cases, antifungal therapy will also be required as part of initial management. This article will provide an overview of the isolation, identification and pathogenicity of Candida species encountered within the mouth and relate these to clinical management of oral candidosis.

Entities:  

Mesh:

Year:  2017        PMID: 29123282     DOI: 10.1038/sj.bdj.2017.886

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  20 in total

Review 1.  Isolation and identification of Candida from the oral cavity.

Authors:  D W Williams; M A Lewis
Journal:  Oral Dis       Date:  2000-01       Impact factor: 3.511

Review 2.  Candida biofilms and oral candidosis: treatment and prevention.

Authors:  David W Williams; Tomoari Kuriyama; Sonia Silva; Sladjana Malic; Michael A O Lewis
Journal:  Periodontol 2000       Date:  2011-02       Impact factor: 7.589

3.  A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity.

Authors:  L P Samaranayake; T W MacFarlane; P J Lamey; M M Ferguson
Journal:  J Oral Pathol       Date:  1986-08

4.  Characterisation of the inflammatory cell infiltrate in chronic hyperplastic candidosis of the oral mucosa.

Authors:  D W Williams; A J Potts; M J Wilson; J B Matthews; M A Lewis
Journal:  J Oral Pathol Med       Date:  1997-02       Impact factor: 4.253

Review 5.  Candidiasis: the emergence of a novel species, Candida dubliniensis.

Authors:  D C Coleman; D J Sullivan; D E Bennett; G P Moran; H J Barry; D B Shanley
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

Review 6.  Candida albicans proteinases and host/pathogen interactions.

Authors:  Julian Naglik; Antje Albrecht; Oliver Bader; Bernhard Hube
Journal:  Cell Microbiol       Date:  2004-10       Impact factor: 3.715

7.  Staphylococcus aureus in the oral cavity: a three-year retrospective analysis of clinical laboratory data.

Authors:  A J Smith; D Robertson; M K Tang; M S Jackson; D MacKenzie; J Bagg
Journal:  Br Dent J       Date:  2003-12-20       Impact factor: 1.626

8.  Association of oral yeast carriage with specific host factors and altered mouth sensation.

Authors:  Chika Shimizu; Tomoari Kuriyama; David W Williams; Tadahiro Karasawa; Katsumi Inoue; Kiyomasa Nakagawa; Etsuhide Yamamoto
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-04

9.  Invasive fungal infections in the intensive care unit.

Authors:  Jose A Vazquez
Journal:  Semin Respir Crit Care Med       Date:  2010-01-25       Impact factor: 3.119

Review 10.  Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia).

Authors:  M A M Sitheeque; L P Samaranayake
Journal:  Crit Rev Oral Biol Med       Date:  2003
View more
  20 in total

1.  Oral medicine: Chronic hyperplastic candidosis.

Authors:  A W Barrett
Journal:  Br Dent J       Date:  2018-06-08       Impact factor: 1.626

2.  The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.

Authors:  Justyna Karkowska-Kuleta; Dominika Bartnicka; Marcin Zawrotniak; Gabriela Zielinska; Anna Kieronska; Oliwia Bochenska; Izabela Ciaston; Joanna Koziel; Jan Potempa; Zbigniew Baster; Zenon Rajfur; Maria Rapala-Kozik
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

3.  Candida albicans CHK1 gene from two-component system is essential for its pathogenicity in oral candidiasis.

Authors:  Yujie Zhou; Lei Cheng; Binyou Liao; Yangyang Shi; Yulong Niu; Chengguang Zhu; Xingchen Ye; Xuedong Zhou; Biao Ren
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-26       Impact factor: 4.813

Review 4.  Antimicrobial Efficacy of Silver Nanoparticles against Candida Albicans.

Authors:  Razia Z Adam; Saadika B Khan
Journal:  Materials (Basel)       Date:  2022-08-18       Impact factor: 3.748

5.  Medium-Chain Fatty Acids Released from Polymeric Electrospun Patches Inhibit Candida albicans Growth and Reduce the Biofilm Viability.

Authors:  Katharina H Clitherow; Tahani M Binaljadm; Jens Hansen; Sebastian G Spain; Paul V Hatton; Craig Murdoch
Journal:  ACS Biomater Sci Eng       Date:  2020-05-20

Review 6.  The regulation of hyphae growth in Candida albicans.

Authors:  Hui Chen; Xuedong Zhou; Biao Ren; Lei Cheng
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

Review 7.  Candida albicans-The Virulence Factors and Clinical Manifestations of Infection.

Authors:  Jasminka Talapko; Martina Juzbašić; Tatjana Matijević; Emina Pustijanac; Sanja Bekić; Ivan Kotris; Ivana Škrlec
Journal:  J Fungi (Basel)       Date:  2021-01-22

8.  Antimicrobial efficacy of silver nanoparticles against Candida albicans: A systematic review protocol.

Authors:  Razia Z Adam; Saadika B Khan
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

Review 9.  Oral Candidiasis: A Disease of Opportunity.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  J Fungi (Basel)       Date:  2020-01-16

Review 10.  Efficacy of Toluidine Blue-Mediated Antimicrobial Photodynamic Therapy on Candida spp. A Systematic Review.

Authors:  Rafał Wiench; Dariusz Skaba; Jacek Matys; Kinga Grzech-Leśniak
Journal:  Antibiotics (Basel)       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.